SCHEDULE: Rock Springs Capital Divests Inozyme Pharma Stake
Beneficial Ownership Report Amendment
Rock Springs Capital and its affiliates have reported a complete divestment of their beneficial ownership in Inozyme Pharma, Inc., now holding 0% of common stock.
Summary
- This is an Amendment No. 3 to a Schedule 13G filing by Rock Springs Capital Management LP, Rock Springs Capital LLC, Rock Springs Capital Master Fund LP, Mark Bussard, and Kris Jenner.
- The filing reports that the reporting persons collectively hold 0.00 shares of Inozyme Pharma, Inc. common stock, representing 0% of the class.
- The event requiring this filing occurred on June 30, 2025.
- The reporting persons certify that the securities were not acquired or held for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 5
Explanation: The filing is neutral as it is an administrative disclosure of a change in beneficial ownership to 0%, without providing operational or financial context for the issuer.
Future Outlook
No forward-looking statements or guidance regarding Inozyme Pharma, Inc.'s operations or financial performance are provided in this beneficial ownership report.
Industry Context
This filing is a standard disclosure of a change in beneficial ownership by an investment firm and does not provide insights into broader industry trends or competitive landscape for Inozyme Pharma, Inc.
Stakeholder Impact
- Shareholders: The divestment by Rock Springs Capital may lead to a perception of reduced institutional confidence, though the filing provides no reasons for the divestment.
Key Dates
| Date | Description |
|---|---|
| 06/30/2025 | Date of event requiring the filing of this statement, indicating the reporting persons' beneficial ownership became 0%. |
| 08/13/2025 | Signature date of the Schedule 13G Amendment No. 3. |
Keywords
Inozyme Pharma, Rock Springs Capital, Schedule 13G, Beneficial Ownership, Divestment, SEC Filing, Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.